[
    [
        {
            "time": "",
            "original_text": "国内CAR-T应用迎突破，延安必康已抢占赛道",
            "features": {
                "keywords": [
                    "CAR-T",
                    "应用突破",
                    "延安必康",
                    "生物制药"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国内CAR-T应用迎突破，延安必康已抢占赛道",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "花红微商“小黑膏”宣称使用30余种名贵苗药可治风湿等 生产企业回应“未使用名贵苗药、确存夸大宣传”",
            "features": {
                "keywords": [
                    "花红微商",
                    "小黑膏",
                    "夸大宣传",
                    "名贵苗药"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "花红微商“小黑膏”宣称使用30余种名贵苗药可治风湿等 生产企业回应“未使用名贵苗药、确存夸大宣传”",
                "Correlation": 2,
                "Sentiment": 3,
                "Importance": 4,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]